Navigation Links
Nominate Your Family Doctor for Family Physician of the Year
Date:1/16/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...n May Be Revealed Friday, January 9 , , WASHIN...rvice Employees International Union (SEIU) Preside...IU International Executive Board to discuss the fo...members out of SEIU United Healthcare Workers-West...he final decision until tomorrow. , , According...
(Date:1/8/2009)... Jude study could shape new treatments for seconda...wire-USNewswire/ -- Scientists at St. Jude Childre...ective treatment for bacterial pneumonia following...mycin and azithromycin, which kill bacteria by inh...e than a standard first-line treatment with the "b...
(Date:1/8/2009).... Jude Children,s Research Hospital have demonstra...onia following influenza. They found that the anti...acteria by inhibiting their protein synthesis, are...nt with the "beta-lactam" antibiotic ampicillin, w...The finding is important because pneumonia, rather...
(Date:1/8/2009)...d Acquisition in 2009 Continues Growth Trend , ,...tCall/ -- IPC The Hospitalist Company, Inc. (Nasda...ian group practice company, announced today that i... Acute Care Consultants, Inc. (MACC) in St. Louis,...pansion in the St. Louis market, where IPC has est...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2
...bosis is a serious complication that can occur in ...and can in turn lead to heart attack, pulmonary em... the result of a research performed in Italy by th...l Epidemiology and the Onco-Haematology Unit of th...
...ics researchers at the Children's Hospital of Phil... Alagille syndrome, a developmental disease with a...inding may have broader implications in the unders...e Children's Hospital team had earlier discovered ...
...g solid food to infants less than six months old i... allergies later and new moms should rather breast...ds of all types should be avoided for the first si... milk, eggs, fish, and nuts should not be introduc...
...dy carried out on approximately 9,000 Danish resid...2 gene might increase three-fold// a woman's risk ...tudy, which was the first to examine the prevalenc...iated with it, in the general population, will be ...
Other Medicine News:Health News:Thrombosis, a Serious Risk in Children with Leukemia 2Health News:Second Alagille Syndrome Gene discovered: More information on kidney disease 2Health News:CHEK 2 Gene Mutation Triples Breast Cancer Risk 2
(Date:1/8/2009)..., Mass. and COLUMBUS, Ohio, Jan. 8 ...prietary nucleic acid assays, today announced that...al Quantitative Assay are complete. , , Under ...linearity, specificity and reproducibility and rob...termined. The data obtain agreed with internally g...
(Date:1/7/2009)...Tenn., Jan. 7 Scientist... a high likelihood of relapse in children with acu...archers caution that further research is needed to... or IKAROS, lead to leukemia relapse, the findin...nostic tests to assess the risk of treatment failu...
(Date:1/7/2009)...Several Products in Development Based On Osteotech...ate Natural BioRegeneration; FDA Filing Anticipate...an. 7 Osteotech, Inc. ...of biologic products for regenerative healing, ann...cal trial for its DuraTech(TM) BioRegeneration Mat...
(Date:1/6/2009)...xpands on Successful Results from prior U.S., U.K....wire/ -- Vital Therapies, Inc. (VTI), a developmen...ounced patient enrollment has begun for a randomiz...al that will study the Extracorporeal Liver Assist...ute Liver Failure (ALF) under three protocols. The...
Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 1University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 2SEIU Endorses Anderson Perea and Perea in Fresno 7229 1SEIU Endorses Anderson Perea and Perea in Fresno 7229 2FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3
...--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therape...lication,of data from a pivotal Phase III clinical... tablets in the June 2007 issue of the,Journal of ... Drug,Administration (FDA) on May 30, 2007. Critic...rtner Dey, L.P. (DEY), expects to,begin marketing ...
...ted at EULAR Confirms Efficacy with Either Every,T... June 2007 - 7:00 am CET - New pivotal data,(RAPID...ongress of,Rheumatology (EULAR) show that Cimzia (...anti-TNF, combined with methotrexate,therapy has a...s,and symptoms of active rheumatoid arthritis (RA)...
Other Medicine Technology:Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications.
DyNA Quant™ 200 is a fixed wavelength fluorometer for 365 nm excitation and 460 nm emission. The spectral characteristics are specifically designed for the detection of double-stranded DNA using
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates.
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C
Medicine Products: